Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
1
Central Research Division, Pfizer Inc, Groton CT 06340, USA
|
Publication type: Journal Article
Publication date: 2001-03-01
scimago Q1
wos Q1
SJR: 3.721
CiteScore: 36.0
Impact factor: 17.6
ISSN: 0169409X, 18728294
PubMed ID:
11259830
Pharmaceutical Science
Abstract
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP > 4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
50
100
150
200
250
300
|
|
|
Molecules
279 publications, 2.77%
|
|
|
Journal of Medicinal Chemistry
260 publications, 2.58%
|
|
|
European Journal of Medicinal Chemistry
254 publications, 2.52%
|
|
|
Journal of Biomolecular Structure and Dynamics
210 publications, 2.09%
|
|
|
Journal of Molecular Structure
197 publications, 1.96%
|
|
|
Journal of Chemical Information and Modeling
160 publications, 1.59%
|
|
|
International Journal of Molecular Sciences
158 publications, 1.57%
|
|
|
Bioorganic and Medicinal Chemistry Letters
157 publications, 1.56%
|
|
|
Bioorganic Chemistry
152 publications, 1.51%
|
|
|
Bioorganic and Medicinal Chemistry
145 publications, 1.44%
|
|
|
Medicinal Chemistry Research
126 publications, 1.25%
|
|
|
Scientific Reports
122 publications, 1.21%
|
|
|
PLoS ONE
111 publications, 1.1%
|
|
|
ChemistrySelect
110 publications, 1.09%
|
|
|
ChemMedChem
90 publications, 0.89%
|
|
|
Pharmaceuticals
90 publications, 0.89%
|
|
|
International Journal of Pharmaceutics
77 publications, 0.77%
|
|
|
ACS Omega
75 publications, 0.75%
|
|
|
Molecular Diversity
74 publications, 0.74%
|
|
|
Future Medicinal Chemistry
71 publications, 0.71%
|
|
|
RSC Advances
68 publications, 0.68%
|
|
|
Journal of Pharmaceutical Sciences
64 publications, 0.64%
|
|
|
Drug Discovery Today
63 publications, 0.63%
|
|
|
Frontiers in Pharmacology
62 publications, 0.62%
|
|
|
Journal of Molecular Graphics and Modelling
61 publications, 0.61%
|
|
|
Molecular Pharmaceutics
59 publications, 0.59%
|
|
|
European Journal of Pharmaceutical Sciences
57 publications, 0.57%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
54 publications, 0.54%
|
|
|
Chemical Biology and Drug Design
54 publications, 0.54%
|
|
|
50
100
150
200
250
300
|
Publishers
|
500
1000
1500
2000
2500
3000
|
|
|
Elsevier
2759 publications, 27.42%
|
|
|
Springer Nature
1347 publications, 13.39%
|
|
|
Wiley
1031 publications, 10.25%
|
|
|
American Chemical Society (ACS)
981 publications, 9.75%
|
|
|
MDPI
851 publications, 8.46%
|
|
|
Taylor & Francis
743 publications, 7.38%
|
|
|
Royal Society of Chemistry (RSC)
301 publications, 2.99%
|
|
|
Bentham Science Publishers Ltd.
255 publications, 2.53%
|
|
|
Frontiers Media S.A.
175 publications, 1.74%
|
|
|
Public Library of Science (PLoS)
143 publications, 1.42%
|
|
|
Cold Spring Harbor Laboratory
95 publications, 0.94%
|
|
|
SAGE
89 publications, 0.88%
|
|
|
Oxford University Press
79 publications, 0.79%
|
|
|
Hindawi Limited
73 publications, 0.73%
|
|
|
American Society for Microbiology
64 publications, 0.64%
|
|
|
Pleiades Publishing
61 publications, 0.61%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
44 publications, 0.44%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
35 publications, 0.35%
|
|
|
Walter de Gruyter
32 publications, 0.32%
|
|
|
King Saud University
32 publications, 0.32%
|
|
|
Mary Ann Liebert
28 publications, 0.28%
|
|
|
Georg Thieme Verlag KG
26 publications, 0.26%
|
|
|
American Society for Biochemistry and Molecular Biology
24 publications, 0.24%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
24 publications, 0.24%
|
|
|
IOP Publishing
23 publications, 0.23%
|
|
|
American Association for the Advancement of Science (AAAS)
22 publications, 0.22%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
20 publications, 0.2%
|
|
|
IGI Global
19 publications, 0.19%
|
|
|
AIP Publishing
18 publications, 0.18%
|
|
|
500
1000
1500
2000
2500
3000
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
10k
Total citations:
10064
Citations from 2025:
965
(9.6%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Lipinski C. A. et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 // Advanced Drug Delivery Reviews. 2001. Vol. 46. No. 1-3. pp. 3-26.
GOST all authors (up to 50)
Copy
Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 // Advanced Drug Delivery Reviews. 2001. Vol. 46. No. 1-3. pp. 3-26.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/S0169-409X(00)00129-0
UR - https://doi.org/10.1016/S0169-409X(00)00129-0
TI - Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
T2 - Advanced Drug Delivery Reviews
AU - Lipinski, Christopher A.
AU - Lombardo, Franco
AU - Dominy, Beryl W
AU - Feeney, Paul J
PY - 2001
DA - 2001/03/01
PB - Elsevier
SP - 3-26
IS - 1-3
VL - 46
PMID - 11259830
SN - 0169-409X
SN - 1872-8294
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2001_Lipinski,
author = {Christopher A. Lipinski and Franco Lombardo and Beryl W Dominy and Paul J Feeney},
title = {Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1},
journal = {Advanced Drug Delivery Reviews},
year = {2001},
volume = {46},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016/S0169-409X(00)00129-0},
number = {1-3},
pages = {3--26},
doi = {10.1016/S0169-409X(00)00129-0}
}
Cite this
MLA
Copy
Lipinski, Christopher A., et al. “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1.” Advanced Drug Delivery Reviews, vol. 46, no. 1-3, Mar. 2001, pp. 3-26. https://doi.org/10.1016/S0169-409X(00)00129-0.